NCT04915131: A trial that was reported late by Bloom Technologies
This trial has reported, although it was 110 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04915131 |
|---|---|
| Title | A Cross-sectional, Interventional, Single-arm Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Fetal Heart Rate and Maternal Heart Rate When Performing Antepartum Fetal Monitoring |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 6, 2021 |
| Completion date | April 28, 2022 |
| Required reporting date | April 28, 2023, midnight |
| Actual reporting date | Aug. 16, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 110 |